Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 11 of 23
Dillico
Angelor
Sector
Biotech
InvestorANGELOR
Entry
2024
Hold
2yr
DNTOX
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Draig Therapeutics
SV7 Impact Medicine Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr
DunAD Therapeutics
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2021
Hold
5yr
Dynamic42
Thueringer Startup-Fonds (TSF)
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2020
Hold
6yr
Dynamic42 GmbH
Thueringer Startup-Fonds (TSF)
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2019
Hold
7yr
Elastrin Therapeutics
KIZOO Evergreen (Balance Sheet)
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2021
Hold
5yr
Emulseo
ACI (Aquitaine Creation Investissement)
Sector
Biotech
InvestorAquiti Gestion
Entry
2017
Hold
9yr
Engrail Therapeutics
Ysios BioFund III
Sector
Biotech
InvestorYsios Capital Partners
Entry
2024
Hold
2yr
EnsiliTech
Elbow Beach Capital
Sector
Biotech
InvestorElbow Beach Investments
Entry
2023
Hold
3yr
Entelo Bio
Ananda Impact Fund IV
Sector
Biotech
InvestorAnanda Impact Ventures
Entry
2024
Hold
2yr
EnteroBiotix
Scottish National Investment Bank (Balance Sheet)
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Enterprise Therapeutics
Panakes Fund Purple
Sector
Biotech
InvestorPanakes Partners SGR
Entry
2024
Hold
2yr
Enthera
Atlante Seed
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2020
Hold
6yr
EpiBiologics
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
EpiBone
EMV Capital Evergreen Fund
Sector
Biotech
InvestorEMV Capital
Entry
2020
Hold
6yr
Epigenomics AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2018
Hold
8yr
Epitopea
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Epsilogen
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2018
Hold
8yr
Eternygen
VC Fonds Technologie Berlin
Sector
Biotech
InvestorIBB Ventures
Entry
2012
Hold
14yr
Etheros
Backed Fund III
Sector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Evox Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
Extend
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
FabricNano
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2019
Hold
7yr
FibroFind
Vespa Capital III
Sector
Biotech
InvestorVespa Capital
Entry
2025
Hold
1yr
Focal Biosciences
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
Formycon
Athos Evergreen Life Sciences
Sector
Biotech
InvestorAthos
Entry
2022
Hold
4yr
Freya Therapeutics
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2023
Hold
3yr
Gandeeva Therapeutics
Leaps by Bayer
Canada
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Gemma Biotherapeutics
Earlybird Health
Sector
Biotech
InvestorEarlybird Venture Capital
Entry
2024
Hold
2yr
Genbioma
Start Up Capital Navarra
Sector
Biotech
InvestorSodena
Entry
2019
Hold
7yr
Genetix Biotherapeutics
The Carlyle Group Portfolio
Sector
Biotech
InvestorThe Carlyle Group
Entry
–
GenoME Diagnostics
Co-Fund NI
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2023
Hold
3yr
Georgiamune
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
Glen Clova Scientific
DSW Ventures
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Glox Therapeutics
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Gordian
10x Founders Fund I
Sector
Biotech
Investor10x Founders
Entry
2021
Hold
5yr
Green Elephant Biotech GmbH
Technologiefonds Hessen
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2022
Hold
4yr
Haptena Therapeutics
Claris Biotech I
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2025
Hold
1yr
Harness Therapeutics
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Hawk Cell
Angelor
Sector
Biotech
InvestorANGELOR
Entry
2024
Hold
2yr
Heidelberg Pharma
dievini Hopp BioTech holding (Evergreen Balance Sheet)
Sector
Biotech
Investordievini Hopp BioTech holding
Entry
2009
Hold
17yr
Helical
Frst 3
Sector
Biotech
InvestorFRST Capital
Entry
2024
Hold
2yr
Heqet Therapeutics
Claris Biotech I
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2022
Hold
4yr
Heqet Therapeutics S.r.l.
Deutsche Balaton Evergreen Holding (Balance Sheet)
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2022
Hold
4yr
Highlight Therapeutics
Columbus Life Science Fund II
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2020
Hold
6yr
Histocell
Fondo BI
Sector
Biotech
InvestorSeed Capital de Bizkaia
Entry
2015
Hold
11yr
HTL
NIO I
Sector
Biotech
InvestorNaxicap Partners
Entry
2017
Hold
9yr
Ikarovec
LifeArc Ventures
Sector
Biotech
InvestorLifeArc
Entry
2020
Hold
6yr
Ilios Therapeutics
Vento Fund I
Sector
Biotech
InvestorVento
Entry
2023
Hold
3yr